http://ift.tt/eA8V8J An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease hereditary thrombotic thrombocytopenic purpura (TTP), according to a study.
from http://ift.tt/2wfszTc
via IFTTT
No comments:
Post a Comment